• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form FWP filed by AptarGroup Inc.

    11/17/25 4:47:35 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    FWP 1 tm2529015d3_fwp.htm FWP

     

    Free Writing Prospectus
    Filed Pursuant to Rule 433
    Registration No. 333-276977
    Supplementing the preliminary prospectus supplement dated November 17, 2025

     

    AptarGroup, Inc.

     

    4.750% Senior Notes due 2031

     

    Pricing Term Sheet

     

    November 17, 2025

     

    Issuer: AptarGroup, Inc.
       

    Expected Ratings

    (Moody’s/S&P/Fitch)*:

    Baa2 (Stable Outlook) / BBB (Stable Outlook) / BBB (Stable Outlook)

       
    Format: SEC Registered
       
    Ranking: Senior Unsecured
       
    Principal Amount: $600,000,000
       
    Trade Date: November 17, 2025
       
    Settlement Date**: November 20, 2025 (T+3)
       
    Maturity Date: March 30, 2031
       
    Interest Payment Dates: Semiannually on March 30 and September 30 of each year, beginning March 30, 2026 (short first coupon)
       
    Benchmark Treasury: 3.625% UST due October 31, 2030
       
    Benchmark Treasury
    Price / Yield:
    99-18+ / 3.719%
       
    Spread to Benchmark Treasury: +105 basis points
       
    Yield to Maturity: 4.769%
       
    Coupon (Interest Rate): 4.750%
       
    Price to Public (Issue Price): 99.917%

     

     

     

     

    Optional Redemption:

    Prior to February 28, 2031 (one month prior to their maturity date) (the “Par Call Date”), the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of:

     

    ·      (a) the sum of the present values of the remaining scheduled payments of principal and interest on the notes to be redeemed discounted to the redemption date (assuming the notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the preliminary prospectus supplement under “Description of Notes — Optional Redemption”) plus 20 basis points less (b) interest accrued to, but not including, the date of redemption, and

     

    ·      100% of the principal amount of the notes to be redeemed,


    plus, in either case, accrued and unpaid interest thereon to, but not including, the redemption date.

     

    On or after the Par Call Date, the Issuer may redeem the notes at its option, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but not including, the redemption date.

       
    Change of Control Repurchase Upon the occurrence of a “Change of Control Repurchase Event” (as defined in the preliminary prospectus supplement under “Description of Notes — Change of Control Repurchase Event”), unless the Issuer has exercised its right to redeem the notes, the Issuer will be required to make an offer to each holder of notes to purchase, at such holder’s option and on the terms described in the preliminary prospectus supplement under “Description of Notes — Change of Control Repurchase Event,” all or a portion of such holder’s notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase.

     

    Joint Book-Running Managers:

    J.P. Morgan Securities LLC

    PNC Capital Markets LLC

    SG Americas Securities, LLC

    Wells Fargo Securities, LLC

    BNP Paribas Securities Corp.

    BofA Securities, Inc.

    HSBC Securities (USA) Inc.

     

     

     

     

    Senior Co-Managers:

    BBVA Securities Inc.

    Deutsche Bank Securities Inc.

    U.S. Bancorp Investments, Inc.

       
    CUSIP / ISIN: 038336 AB9 / US038336AB93

     

     

    * Note: A securities rating is not a recommendation to buy, sell or hold securities and may be revised or withdrawn at any time.

     

    ** It is expected that delivery of the notes will be made to investors on or about November 20, 2025, which will be the third business day following the date hereof (such settlement being referred to as “T+3”). Under Rule 15c6-1 under the Exchange Act of 1934, as amended, trades in the secondary market are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers of the notes who wish to trade the notes prior to the business day before their date of delivery will be required, by virtue of the fact that the notes will initially settle in T+3, to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to the business day before their date of delivery should consult their own advisors.

     

    The Issuer has filed a registration statement (including a prospectus and preliminary prospectus supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling J.P. Morgan Securities LLC at (212) 834-4533, PNC Capital Markets LLC at (855) 881-0697, SG Americas Securities, LLC at (855) 881-2108 or Wells Fargo Securities, LLC at (800) 645-3751.

     

    Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.

     

     

     

     

    Get the next $ATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    3/20/2026$144.00Equal Weight → Overweight
    Wells Fargo
    1/6/2026$133.00Overweight → Equal Weight
    Wells Fargo
    11/3/2025Outperform → Mkt Perform
    William Blair
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tlili Hedi

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:24:51 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Kanu Vanessa

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/20/26 2:22:49 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 4 filed by Tanda Stephan B.

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    3/19/26 8:20:10 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    AptarGroup upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded AptarGroup from Equal Weight to Overweight and set a new price target of $144.00

    3/20/26 8:27:39 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AptarGroup from Overweight to Equal Weight and set a new price target of $133.00

    1/6/26 8:44:42 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by William Blair

    William Blair downgraded AptarGroup from Outperform to Mkt Perform

    11/3/25 9:08:28 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    AptarGroup Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    3/17/26 5:23:41 PM ET
    $ATR
    Plastic Products
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AptarGroup Inc.

    SCHEDULE 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/11/26 12:08:11 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 10-K filed by AptarGroup Inc.

    10-K - APTARGROUP, INC. (0000896622) (Filer)

    2/6/26 11:57:37 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray

    Use of Aptar Pharma's UDS Powder system supports the development of a next‑generation, virus‑agnostic nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its Unidose (UDS) Powder Nasal Spray System is being utilized in ENA Respiratory's Phase II clinical study of INNA 051, an investigational nasal spray being evaluated for its potential to help protect against symptomatic viral respiratory infections. This collaboration reflects the growing role of intranasal delivery technologies

    3/19/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray

    Supporting advancement of complex intranasal therapies through clinical development AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that its proprietary nasal delivery system is being utilized in LTR Pharma Limited's (ASX:LTP) Phase II clinical study of SPONTAN®, an investigational intranasal spray under development for the treatment of erectile dysfunction. This milestone reflects Aptar Pharma's continued commitment to supporting intranasal drug delivery technologies and supporting the development of innovative, patient-centric therapies. This press release features multimedia. View the f

    3/16/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that Gael Touya, a seasoned global executive with more than 30 years of experience at the company, most recently as Aptar Pharma President, has been appointed President and Chief Executive Officer, effective September 1, 2026. He will succeed Stephan B. Tanda, who has served as President and Chief Executive Officer since 2017. Stephan is expected to continue to work closely with Gael and the Board as an advisor through the end of the year to help ensure a seamless transition as the company enters its next phase of growth. Stephan intends to reti

    3/17/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Reports Fourth Quarter and Annual 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260205227722/en/Photo: Aptar Fourth Quarter 2025 Highlights (Compared to the prior year quarter; see Non-GAAP section for full definitions; see reconciliation for Non-GAAP measures) Reported sales increased 14% and core sales increased 5%—all three segments delivered core sales growth Reporte

    2/5/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.48 per share. The payment date is February 25, 2026, to stockholders of record as of February 4, 2026. As previously announced, Aptar will hold a conference call on Friday, February 6, 2026, at 8:00 a.m. Central Time to discuss the Company's fourth quarter and year-end results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. A replay of the conference call can also be accessed fo

    1/22/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces 2026 Quarterly Conference Call Dates

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases. Quarterly Conference Calls   Press Release(1) Conference Call(2) 4th Quarter and Annual 2025 Results February 5, 2026 February 6, 2026, at 8:00 a.m. CT 1st Quarter 2026 Results April 30, 2026 May 1, 2026, at 8:00 a.m. CT 2nd Quarter 2026 Results July 30, 2026 July 31, 2026, at 8:00 a.m. CT 3rd Quarter 2026 Results

    1/7/26 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials